A screening protocol to determine tumor antigen expression and HLA sub-type ofr eligibility determination for clinical trials evaluating the safety and efficacy of Autologous T Cell expressing enhance

Administered By

Awarded By

Contributors

Start/End

  • February 1, 2016 - January 31, 2023